Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older

Autor: Schwarz, Tino F., Aggarwal, Naresh, Moeckesch, Beate, Schenkenberger, Isabelle, Claeys, Carine, Douha, Martine, Godeaux, Olivier, Grupping, Katrijn, Heineman, Thomas C., Fauqued, Marta Lopez, Oostvogels, Lidia, Van den Steen, Peter, Lal, Himal

Publikováno v: The Journal of Infectious Diseases, 2017 Dec 01. 216(11), 1352-1361.

Externí odkaz: https://www.jstor.org/stable/26491555

The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70.

Autor: Boutry C; Aixial, an Alten Company, Brussels, Belgium, C/O GSK, Wavre, Belgium., Hastie A; GSK, Rockville, Maryland, USA., Diez-Domingo J; FISABIO Fundación para el Fomento Investigación Sanitaria y Biomédica de la Comunitat Valenciana, Valencia, Spain., Tinoco JC; Hospital General de Durango, Durango, Mexico., Yu CJ; Department of Internal Medicine, National Taiwan University College of Medicine and National Taiwan University Hospital, Taipei, Taiwan., Andrews C; Diagnostics Research Group, San Antonio, Texas, USA., Beytout J; Service CIC, CHU Clermont-Ferrand, Clermont-Ferrand, France., Caso C; Servicio de Prevención, Hospital Clínico San Carlos, Madrid, Spain., Cheng HS; Linkou Chang Gung Memorial Hospital, Taoyuan City, Taiwan., Cheong HJ; Korea University Guro Hospital, Seoul, Republic of Korea., Choo EJ; SoonChunhyang University Bucheon Hospital, Bucheon-si, Republic of Korea., Curiac D; Clinical Trial Center, SU/Sahlgrenska Universitetssjukhuset, Göteborg, Sweden., Di Paolo E; GSK, Rixensart, Belgium., Dionne M; CHU de Québec-Université Laval, Québec City, Canada., Eckermann T; Praxisgemeinschaft Heimeranplatz, München, Germany., Esen M; Institute of Tropical Medicine, Universitätsklinikum Tübingen, Tübingen, Germany., Ferguson M; Colchester Research Group, Truro, Canada., Ghesquiere W; Division of Infectious Diseases, UBC, Island Health Authority, PerCuro Clinical Research Ltd., Victoria, Canada., Hwang SJ; Taipei Veterans General Hospital, Taipei City, Taiwan.; National Yang Ming University School of Medicine, Taipei City, Taiwan., Avelino-Silva TJ; Laboratório de Investigação Médica em Envelhecimento (LIM-66), Serviço de Geriatria, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil., Kosina P; Department of Infectious Diseases, Hradec Kralove, Czechia., Liu CS; Occupational Medicine and Family Medicine, China Medical University Hospital, Taichung, Taiwan., Markkula J; Pori Vaccine Research Clinic, Vaccine Research Center, Tampere University, Pori, Finland., Moeckesch B; Praxis Dr. med. Beate Moeckesch, Weinheim, Germany., Murta de Oliveira C; Ambulatório de Pesquisa Clínica, Santa Casa de Misericórdia de Belo Horizonte, Belo Horizonte, Brazil., Park DW; Korea University Ansan Hospital, Ansan, Republic of Korea., Pauksens K; Akademiska sjukhuset, Infektionskliniken, Uppsala, Sweden., Pirrotta P; GSK, Wavre, Belgium., Plassmann G; UHZ Klinische Forschung, Essen, Germany., Pretswell C; Synexus Lancashire Clinical Research Centre, Chorley, United Kingdom., Rombo L; Clinical Research Centre, Eskilstuna, Sweden., Salaun B; GSK, Rixensart, Belgium., Sanmartin Berglund J; Blekinge Institute of Technology, Department of Health, Karlstrona, Sweden., Schenkenberger I; KFB- Klinische Forschung Berlin, Berlin, Germany., Schwarz T; Institute of Laboratory Medicine and Vaccination Centre, Klinikum Würzburg Mitte, Standort Juliusspital, Würzburg, Germany., Shi M; GSK, Rockville, Maryland, USA., Ukkonen B; Espoo Vaccine Research Clinic, Vaccine Research Center, Tampere University, Espoo, Finland., Zahaf T; GSK, Wavre, Belgium., Zerbini C; Centro Paulista de Investigação Clínica, CEPIC, São Paulo, Brazil., Schuind A; GSK, Rockville, Maryland, USA., Cunningham AL; The Westmead Institute for Medical Research, Westmead, NSW, Australia.; University of Sydney, Sydney, NSW, Australia.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 Apr 28; Vol. 74 (8), pp. 1459-1467.